Cochrane Abstracts
First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"First‐line Therapy for Adults With Advanced Renal Cell Carcinoma: a Systematic Review and Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440462/all/First‐line_therapy_for_adults_with_advanced_renal_cell_carcinoma:_a_systematic_review_and_network_meta‐analysis.
First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440462/all/First‐line_therapy_for_adults_with_advanced_renal_cell_carcinoma:_a_systematic_review_and_network_meta‐analysis. Accessed January 20, 2025.
First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440462/all/First‐line_therapy_for_adults_with_advanced_renal_cell_carcinoma:_a_systematic_review_and_network_meta‐analysis
First‐line Therapy for Adults With Advanced Renal Cell Carcinoma: a Systematic Review and Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440462/all/First‐line_therapy_for_adults_with_advanced_renal_cell_carcinoma:_a_systematic_review_and_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis
ID - 440462
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440462/all/First‐line_therapy_for_adults_with_advanced_renal_cell_carcinoma:_a_systematic_review_and_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
